Overview

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to examine the effect of zoledronic acid and alendronate on bone metabolism as measured by biomarkers in postmenopausal women with osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Alendronate
Calcium
Calcium, Dietary
Diphosphonates
Ergocalciferols
Pharmaceutical Solutions
Vitamin D
Vitamins
Zoledronic Acid